Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.

Mancarella L;Bobbio Pallavicini F;Ceccarelli F;Falappone PC;Ferrante A;Malesci D;Massara A;Nacci F;Secchi ME;Manganelli S;Salaffi F;Bambara ML;Bombardieri S;CUTOLO, MAURIZIO;Ferri C;Galeazzi M;Gerli R;Giacomelli R;Grassi W;Lapadula G;Cerinic MM;Montecucco C;Trotta F;Triolo G;Valentini G;Valesini G;Ferraccioli GF;GISEA group

2007-01-01